Quick answer: A drug testing kit for pills is a urine or oral fluid screen that detects prescription pill drug classes in the person, not in the tablet. Typical cutoffs: oxycodone 100 ng/mL, benzodiazepines 300 ng/mL, amphetamine 500 ng/mL, with windows of about 1-3 days. American Screening Corp supplies FDA-cleared, CLIA-waived cups; positives are preliminary and need GC/MS or LC-MS/MS confirmation.
- Detects: drugs and metabolites in urine or saliva (opioids, benzodiazepines, amphetamines, buprenorphine, methadone and more), not the identity of an unknown tablet.
- Cutoffs and windows: set per drug in ng/mL; most pill classes show for roughly 1-3 days after use, longer with heavy or chronic use.
- Every positive is preliminary: confirm by GC/MS or LC-MS/MS laboratory testing before any action.
What does a drug testing kit for pills actually test?
It tests a specimen from a person. A urine cup or dip card reacts to a drug or its metabolite at or above a set cutoff concentration. It does not tell you what an unidentified tablet contains.
Need drug tests for your clinic, program or workplace?
American Screening Corp has supplied FDA-cleared, CLIA-waived tests at wholesale pricing since 2004. Popular options:
Ordering 100+ tests? Request volume pricing.
For clinics, treatment centers, courts and employers, the question is usually whether a person has taken prescription-type drugs such as opioid pain relievers, sedatives or stimulants. A multi-panel drug test cup answers that in minutes at the point of collection.
Which pill drug classes can be screened, and at what cutoffs?
Cutoffs are the concentration (ng/mL) at which a result reads positive. The HHS Mandatory Guidelines for urine set federal initial test cutoffs, as of the current SAMHSA guidelines page: amphetamines 500 ng/mL, oxycodone/oxymorphone 100 ng/mL, hydrocodone/hydromorphone 300 ng/mL, and morphine/codeine 2,000 ng/mL. Benzodiazepines are not in the federal panel; commercial cups commonly use 300 ng/mL.
Always read the package insert for the exact cutoff and calibrator of the lot you stock. Cutoffs for buprenorphine, methadone, tramadol and fentanyl vary by product.
| Drug class | Typical cutoff (ng/mL) | Typical window | Common use |
|---|---|---|---|
| Oxycodone (OXY) | 100 | 1-3 days | Pain-management monitoring, treatment programs |
| Opiates (morphine/codeine) | 2,000 (federal) or 300 (common commercial) | 1-3 days | Employment, probation |
| Benzodiazepines (BZO) | 300 | 1-7 days, longer with chronic use | Clinics, courts |
| Amphetamines (AMP) | 500 or 1,000 | 1-3 days | Employers, probation |
| Buprenorphine (BUP) | 10 | 2-4 days | Treatment adherence |
| Methadone (MTD) | 300 | 2-4 days | Treatment adherence |
Windows are general ranges. Dose, frequency, metabolism and hydration change them, per NIDA drug testing guidance.
Is the kit FDA-cleared and CLIA-waived?
Look for both. FDA clearance means the device was reviewed for its intended use as a drugs-of-abuse test. CLIA-waived status allows use in non-laboratory settings under a Certificate of Waiver. American Screening Corp supplies FDA-cleared, CLIA-waived urine cups and dip cards; verify the clearance and waiver status of each specific panel on its product page or insert before you buy.
How do you read and handle a result?
- Check the cup temperature strip within four minutes of collection, if the cup has one.
- Read the result at the time stated in the insert, usually 5 minutes, and not after the stated read window.
- A line in the control region confirms the test worked; a visible line in a drug region means negative for that drug.
- No line in a drug region means a non-negative result at or above the cutoff.
- Record the lot number, time and reader, and label the sample.
- Send any non-negative specimen for GC/MS or LC-MS/MS confirmation.
A non-negative screen is preliminary. It cannot distinguish a prescribed pill from a non-prescribed one, so a medical review of prescriptions should occur before any decision.
How should you choose a pill-screening kit for your program?
- Match panel drugs to your policy and the drugs you actually see in your population.
- Confirm the cutoffs on the insert against your written policy.
- Verify FDA clearance and CLIA-waived status for the exact panel.
- Decide whether you need adulterant checks and a temperature strip.
- Arrange laboratory confirmation for every preliminary positive.
- For DOT-regulated testing, follow 49 CFR Part 40; point-of-collection cups alone do not satisfy it.
- For employment screening alongside testing, see our sister division Reveal Background.
What do we hear from buyers?
Buyers most often ask whether one cup can cover opioids, benzodiazepines and stimulants together, and whether a kit can identify a loose pill. The first is yes, with a multi-drug panel. The second is no: a urine screen reflects what is in the body, not in the tablet.
For bulk pricing, private label or panel recommendations, contact American Screening Corp in Shreveport, Louisiana. We ship same day nationwide.
FAQ
Can a drug test kit identify an unknown pill?
No. Urine and oral fluid kits detect drugs or metabolites in a person's specimen at set cutoffs. They do not identify the contents of a tablet.
How long do pill drugs stay detectable in urine?
Most opioids, stimulants and methadone are detectable for about 1-4 days. Benzodiazepines can be detectable 1-7 days or longer with chronic use, per NIDA guidance.
Is a positive pill screen final?
No. Every positive is preliminary and must be confirmed by GC/MS or LC-MS/MS laboratory testing, with a review of valid prescriptions.
Are the kits FDA-cleared and CLIA-waived?
American Screening Corp supplies FDA-cleared, CLIA-waived cups and dip cards. Confirm each panel's status on its product page and insert.
Sources
- SAMHSA: Mandatory Guidelines for Federal Workplace Drug Testing Programs
- eCFR: 49 CFR Part 40, Procedures for Transportation Workplace Drug and Alcohol Testing Programs
- FDA: Drugs of Abuse Tests
This article is general information, not legal or medical advice.
